I am a clinician-scientist specializing in acute myeloid leukemia and myelodysplastic syndromes. My research focuses on the clinical implementation of whole-genome sequencing, genomic epidemiology, the integration of genomic and registry data, and automated genomic risk stratification. I have experience in laboratory research, including PCR, flow cytometry, and cell culture. I am a member of the boards of ALG, the Nordic AML Group, and the Scientific Advisory Council of the National Genome Center (NGC).